Saturday 7 November 2026 Export CCM’s income statement to Excel — free account

Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.

3.71 0.15 +4.21%

Follow CCM

Alert me

Market cap: $10.0M
P/E: 0.0×
Fwd P/E: −4.4×
Dividend yield: —
F-score: 6/9
Altman Z: −1.20
Beneish M: −5.04
Dividend safety: n/a

Overview

Insider Decisions last twelve months

Trades a month
	Jan 26			Apr 26			Jul 26			Oct 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 45.88%

Capital & Financial Ratios $m

Size

Market Cap 10.04

Revenue ttm 155.78

Net income ttm (53.70)

Free cash flow ttm 67.56

Net debt Q 395.45

Valuation

P/E 0.00

Forward P/E (4.39)

Price / sales 0.10

Forward P/S Powerpack

Price / FCF 0.24

Price / book 0.07

Financial health

Current ratio Q 0.42

Debt / equity Q 1.76

Interest coverage Q 0.00

Growth

Revenue growth Q +37.65%

Operating income growth Q −152.32%

EPS, this year —

EPS, next year A —

Revenue, next year A −100.00%

EPS, past 5 yrs —

EPS, next 5 yrs A +20.00%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 1.91%

10-year low 10-year high

P/B against its own 10 years 3.73%

10-year low 10-year high

EV/Sales against its own 10 years 52.09%

10-year low 10-year high

EV/FCF against its own 10 years 65.91%

10-year low 10-year high

Dividends

Yield: —
Annual rate: —
Payout ratio: —

Assets vs Liabilities $m

	2022	2023	2024	2025
Cash	23	13	51	43
Receivables	19	10	7	6
Inventory	12	6	5	7
Other	—	—	—	—
	110	87	135	135

	2022	2023	2024	2025
Payables	21	18	27	17
ST’ Debt	50	102	52	79
Other	61	0	—	—
	163	275	291	279

Compound Annual Growth %

	10y	5y	3y
Sales	(3.62%)	14.02%	(1.28%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	1.80%	0.00%	(3.26%)

Earnings Trends EPS, adjusted, against the consensus

Jun 2016 Estimate 2.10 Actual −0.60

−5.60 −3.43 −1.25 0.93 3.10

Sep 2015 Beat +0.70

Dec 2015 Miss −3.70

Mar 2016 Miss −2.30

Jun 2016 Miss −2.70

Earnings per share against the consensus, by quarter
Quarter	Estimate	Reported	Result
Sep 2015	0.20	0.90	Beat by 0.70
Dec 2015	−0.90	−4.60	Miss by 3.70
Mar 2016	1.20	−1.10	Miss by 2.30
Jun 2016	2.10	−0.60	Miss by 2.70

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(3.04)
’24	—	—	—	—	(9.67)
’23	—	—	—	—	(9.60)
’22	—	—	—	—	(16.20)
’21	—	—	—	—	(29.40)
’20	—	—	—	—	(23.40)

Fiscal quarters ending in the months shown.

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	66
’24	—	—	—	—	53
’23	—	—	—	—	76
’22	—	—	—	—	68
’21	—	—	—	—	76
’20	—	—	—	—	34

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(29)
’24	—	—	—	—	(54)
’23	—	—	—	—	(39)
’22	—	—	—	—	(31)
’21	—	—	—	—	(56)
’20	—	—	—	—	(35)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(36)
’24	—	—	—	—	(111)
’23	—	—	—	—	(55)
’22	—	—	—	—	(63)
’21	—	—	—	—	(70)
’20	—	—	—	—	(62)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	Trend	10 yrs	2026e	2027e	2028e	Next 3/yr
												Ten-year view		Analyst estimates Powerpack
Income, $m
Income, $m	Revenue	66	51	28	28	34	76	68	76	53	66		+0.1%	—	—	—	—
	Gross margin, %	37.03	29.61	10.35	(7.98)	5.87	(11.72)	(32.28)	(14.26)	(20.62)	5.61		(31.4) pt	Powerpack Concord Medical Services Holdings Limited’s next three years, line by line See the consensus for every other line: earnings, margins, cash flow, valuation and returns. Unlock estimates Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time. Also in Powerpack: every quarter, Excel exports, API & MCP access. Compare plans
	EBT	(29)	(39)	(33)	(56)	(68)	(83)	(122)	(78)	(92)	(53)		+6.8%
	EBT margin, %	(44.96)	(76.71)	(117.99)	(197.15)	(198.05)	(108.98)	(177.91)	(103.39)	(174.39)	(81.07)		(36.1) pt
	Net income	(38)	(44)	(38)	(51)	(62)	(82)	(111)	(75)	(89)	(54)		+4.0%
Per share, $
Per share, $	Revenue	15.05	11.73	6.40	6.56	7.82	17.44	15.67	17.33	12.04	15.08		0.0%
	Earnings	(8.70)	(10.20)	(12.00)	(18.30)	(23.40)	(29.40)	(16.20)	(9.60)	(9.67)	(3.04)		(11.0%)
	Cash flow	(2.58)	0.95	(1.29)	(6.46)	(8.06)	(12.91)	(7.19)	(8.91)	(12.47)	(6.61)		+11.0%
	Capex	(2.25)	(1.75)	(1.74)	(5.42)	(6.17)	(3.08)	(7.25)	(3.77)	(12.89)	(1.60)		(3.7%)
	Free cash flow	(4.83)	(0.80)	(3.03)	(11.89)	(14.23)	(15.99)	(14.44)	(12.68)	(25.36)	(8.21)		+6.1%
	Book value	40.74	35.98	18.56	(0.67)	(17.99)	(33.66)	66.90	56.33	50.74	60.57		+4.5%
	Shares, m	4	4	4	4	4	4	4	4	4	4		0.0%
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.0
	P/S	2.18	1.63	2.26	2.03	1.97	0.82	0.55	0.32	0.15	0.11		1.2
	P/B	0.93	0.70	2.46	0.00	0.00	0.00	0.00	0.18	0.09	0.07		0.4
	EV/Sales	1.74	1.20	2.39	6.45	7.00	4.53	3.60	2.57	2.51	2.65		3.5
	EV/FCF	2.39	1.64	2.45	5.51	6.34	7.23	7.70	5.92	5.79	6.10		5.1
Cash, $m
Cash, $m	Operating cash flow	(11)	4	(6)	(28)	(35)	(56)	(31)	(39)	(54)	(29)		+11.0%
	Capex	(10)	(8)	(8)	(24)	(27)	(13)	(32)	(16)	(56)	(7)		(3.7%)
	Free cash flow	(21)	(3)	(13)	(52)	(62)	(70)	(63)	(55)	(111)	(36)		+6.1%
Balance, $m
Balance, $m	Working capital	35	0	52	(50)	25	(35)	(52)	(188)	(156)	(145)		n/m
	Net debt	(32)	(6)	(53)	176	265	342	385	370	371	389		n/m
	Shareholders’ equity	177	156	81	(3)	(79)	(147)	292	246	222	265		+4.5%
Returns, %
Returns, %	ROA	(7.39)	(8.76)	(8.71)	(12.36)	(14.31)	(14.35)	(7.68)	(4.87)	(4.76)	(1.43)		+6.0 pt
	ROIC	(10.42)	(13.52)	(99.09)	(22.69)	(16.25)	(23.05)	(7.02)	(6.62)	(7.69)	(3.58)		+6.8 pt
	ROE	(18.92)	(26.21)	(44.19)	(204.60)	251.88	114.14	(97.79)	(15.58)	(18.06)	(5.46)		+13.5 pt
People
People	Employees	739	583	584	738	851	972	918	727	595	610		(2.1%)
	Revenue/emp, $m	0.09	0.09	0.05	0.04	0.04	0.08	0.07	0.10	0.09	0.11		+2.2%

Negative figures in brackets.

estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2016

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BMGL Basel Medical Group Ltd	$70.5M	—	—	—	—	—	—	—	Compare
CCEL Cryo-Cell International Inc.	$39.9M	— (loss-making)	65.1×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
BTMD biote Corp.	$37.4M	6.6×	— (loss-making)	−9.48% (below 0%: shrinking)	n/m	−174.16% (below 0%: shrinking)	65.38%	(7.93%)	Compare
PIII P3 Health Partners Inc.	$28.1M	— (loss-making)	—	+8.60% (above 0%: growing)	n/m	−272.24% (below 0%: shrinking)	22.26%	10.67%	Compare
DCGO DocGo Inc.	$24.1M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)	Compare
CCM Concord Medical Services Holdings Limited	$10.0M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%
AMS American Shared Hospital Services	$7.8M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)	Compare
RHEP Adcare Health Systems Inc	$5.2M	0.6×	— (loss-making)	+143.03% (above 0%: growing)	n/m	+224.45% (above 0%: growing)	31.50%	(0.88%)	Compare
SYRA Syra Health Corp.	$1.1M	14.7×	—	+51.50% (above 0%: growing)	n/m	+235.76% (above 0%: growing)	46.34%	11.73%	Compare
Median of peers	$26.1M	6.6×	—	+8.60%	—	−58.37%	31.50%	(0.88%)

All 51 Medical Care Facilities stocks →